NCT02192957View on ClinicalTrials.gov

The Ottawa AF Cardioversion Protocol

NACompletedINTERVENTIONAL

Enrollment

389

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

April 30, 2018

Conditions

Atrial Fibrillation

Interventions

DEVICE

Lifepak 20E Defibrillator, Licence No: 61944

"Intervention will be carried out using Health Canada approved devices for electrical cardioversion, following the steps pre-specified in the Ottawa AF Protocol.~Ottawa AF Cardioversion"

Trial Locations (1)

K1Y 4W7

University of Ottawa Heart Institution, Ottawa

All Listed Sponsors

lead

David Birnie

OTHER

NCT02192957 - The Ottawa AF Cardioversion Protocol | Biotech Hunter | Biotech Hunter